SEC Form 4 · accession 0001209191-19-001532
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Lerner
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 31, 2018 | A | 1,207 | $11.39 | A | 11,430 | D | |
| Common StockF1 | holding | — | — | — | 66,911 | I | Held by the Lerner Family Trust UAD 11/14/94 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.